Download Overview of Paediatric Oncology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Overview of Paediatric Oncology in Malawi

 Peter Wasswa MBCHB, MRCP,
MRCPCH, FRCPath
 Consultant Paediatric Haematologist
Kamuzu Central Hospital
 Assistant Professor of Pediatrics
Baylor College of Medicine
 Director,
Malawi program, Global Hematology Oncology
Programs of Excellence, Texas Children’s Hospital.
Overview
 Significance of childhood Cancer- How common,
How important?
 Resources in Malawi- diagnostic, treatment- curative
and supportive, including palliation
 Research infrastructure- what has been done, what is
being done, what is planned, opportunities,
GLOBOCAN 2012
 14067.9 (X103) new cancer cases
 8201.6 (X103) cancer deaths
 18.5% risk of a cancer diagnosis before age 75 years)
 Risk of dying from cancer at age <75 yrs. 10.5%
Globocan 2012
Cancer incidence by age group
GLOBOCAN 2012
1800
1600
1400
1200
1000
Series1
800
600
400
200
0
0-14
15-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
Child statistics 0-14yrs
 0-14yrs: 163284 (1.1% of all new cases worldwide)
 64% in LMIC
High Vs LMIC
Incidence rate
Number
16
120000
14
100000
12
80000
10
60000
8
Incidence rate
6
Number
40000
4
20000
2
0
0
Low
Medium
High
Very high
Low and
medium
High
Very high
Cancer subtypes 0-14yrs- World
Type
numb %
e
Leukae 49,752 30.4
60000
brain
20,105 12.3
50000
NHL
16,514 10.1
40000
30000
Kidney 9,656
6
Hodgk 6,744
ins
4
20000
Liver
3,529
2.2
10000
KS
2,163
1.32
Thyroi 1,715
d
1
NPC
0.7
1,204
0
Series1
Cancer subtypes 0-14, GLOBOCAN 2012
Malawi
Sub-Saharan Africa
percentage
percentage
1.5 0.4
22
3
NHL
Leukaemia
44
10.4
2 4.2
7.4
2
1
NHL
KS
6
Kidney
Kidney
liver
KS
Hodgkins
Hodgkins
Brain
10
2.7
other
16.3
47.5
Brain
Testes
Leukaemia
NPC
0-14 Years Kyaddondo
County, Uganda 1993-1997
Blantyre
Why is it different for SSA?
 Genetics
 Environmental
 Social Economic
 Superfluous- diagnostic challenges
 Incomplete data collection/registries
Childhood cancer incidence in South
Africa, 1987 – 2007 Stefan etal S Afr Med J 2015
30
25
20
15
10
5
0
Series1
Leukaemia as a proportion of Ethnicity specific
cancer incidence rates RSA
45
40
35
30
25
Series1
20
15
10
5
0
black
white
coloured
Asian
What we see at KCH
07/2015 to 07/2016
12/ 2011- 06/2013
40
30
35
25
30
25
20
20
15
Series1
15
10
10
5
0
5
0
Series1
07/2015 to 07/2016
GLOBOCAN 2012 DATA
40
500
450
35
400
30
350
25
300
20
250
200
150
100
Series1
15
10
5
50
0
0
Series1
Rationale for splitting adult and paediatric cancer
services
 Childhood cancer is rare
 Different incident/prevalent cancer subtypes
 Better outcomes for children in paediatric
environments
 Differences in physiology, physical and mental
growth
 Unique psycho-social, and educational needs for
children
 Late effects more significant.
QECH- Blantyre
 Child cancer treatment since 1964
 17 beds
 Dr George Chagaluka-Paediatric Oncologist,




resident, Clinical officer
5 nurses
Play lady
Social worker
Data manager
QECH resources
 Paediatric surgery
 Neurosurgery
 Paediatric subspecialties
 Pathology
 Radiology- MRI
 Blood bank
 Palliative care
KCH-1
 Paediatric Haematologist
 2 medical officers
 4 clinical officers
 2 nurses + 1
 UNC lymphoma study staff.
 Increased scope from July 2015
 Paediatric Surgeon 2016
 More to come!
KCH- resources
 General Paediatrics and retrovirology
 Pathology services KCH + UNC lab + Baylor
 Paediatric Surgery
 Radiology- CT
 Intensive Care
 Blood Bank
 Dietetics
 Pharmacy
Outcomes
 KCH data, Dec 2011 to June 2013; Sustained CR:
(74/271 (27%) (median follow-up 19 months) Mtete
et al 2015
 BL 18month OS: 29% (95% CI 18-41%) Stanley et al
BJH 2016
 Lymphoma, Leukaemia, Wilms, Retinoblastoma
contribute 83% of new non KS childhood cancer
diagnoses (KCH data July 2015 to June 2016)
Obstacles
 Late presentation
 Limited diagnostic resources.
 Supportive care limitations
 Limited specific treatment options
 Psycho social support
 Treatment abandonment
 Sustainability
Bridging the gap
 Local and International partners- MOH, Newcastle,






World Child Cancer, BCM, UNC
Care and research
Human resource capacity and training
Diagnostic infrastructure- flow cytometry , IHC, etc
BL new treatment strategies- HD MTX
80% CR rates for ALL, all maintained at >6months,
Safe navigation of AML induction
Radiotherapy
Conclusion
 Significant numbers of childhood cancer in Malawi
 Mostly curable cancers
 Poor outcomes
 Opportunities to do better
 The future looks bright.
Any questions?
THANK YOU
QUESTIONS